Case Type: Mergers & Acquisitions

We are investigating Finisar Corporation (“Finisar” or the “Company”) (NasdaqGS: FNSR) relating to the sale of the Company to II-VI Incorporated (“IIVI”). As a result of the merger, Finisar shareholders are only anticipated to receive $15.50 per share in cash and 0.2218 IIVI common shares for each share of Finisar that they own.

We are investigating Edge Therapeutics, Inc. (“Edge” or the “Company”) (NasdaqGS:EDGE) relating to the sale of the Company to PDS Biotechnology Corporation. As a result of the transaction, Edge Therapeutics shareholders will own 30% of the combined company.t

We are investigating BSB Bancorp, Inc. (“BSB” or the “Company”) (NasdaqCM:BLMT) relating to the sale of the Company to People’s United Financial, Inc. (“People’s United”). As a result of the merger, BSB shareholders are only anticipated to receive 2 shares of People’s United for each share of BSB they own.

We are investigating Bojangles’, Inc. (“Bojangles” or the “Company”) (NasdaqGS:BOJA) relating to the sale of the Company to Durational Capital Management LP and the Jordan Company. As a result of the merger, Bojangles’ shareholders are only anticipated to receive $16.10 per share.

We are investigating athenahealth, Inc. (“athenahealth” or the “Company”) (NasdaqGS:ATHN) relating to the sale of the Company to affiliates of Veritas Capital and Evergreen Coast Capital. As a result of the merger, athenahalth shareholders are only anticipated to receive $135.00 per share.

We are investigating Apptio, Inc. (“Apptio” or the “Company”) (NasdaqGM: APTI) relating to the sale of the Company to affiliates of Vista Equity Partners. As a result of the merger, Apptio shareholders are only anticipated to receive $38.00 per share.

We are investigating Birner Dental Management, Inc. (”BDMS” or the ”Company”) (OTC: BDMS) relating to the sale of the Company to Mid-Atlantic Dental Services Holdings, LLC. As a result of the agreement, BDMS shareholders will receive $10.62 in cash for each BDMS share they own.

We are investigating OvaScience, Inc. (“OvaScience” or the “Company”) (NasdaqCM: OVAS) relating to the merger of the Company with Millendo Therapeutics. As a result of the agreement, OvaScience shareholders will own approximately 20% of the combined company and current Millendo investors will own approximately 80% of the combined company.

We are investigating the Board of Directors of Dover Downs Gaming & Entertainment, Inc. (“Dover Downs” or the “Company”) (NYSE:DDE) for possible breaches of fiduciary duty related to the proposed acquisition of the company by Twin River Worldwide Holdings, Inc. (“Twin River”). Under the terms of the proposed transaction, Dover Downs’ shareholders are anticipated to … Read more

We are investigating Black Box Corporation (“Black Box” or the “Company”) (NasdaqGS: BBOX) relating to the sale of the Company to affiliates of AGC Networks Ltd. (“AGC”). Under the terms of the transaction, Black Box shareholders will receive only $1.08 in cash for each share of Black Box stock they own.